MarketCap
Facebook
X
TelegramAlexion Pharmaceuticals, Inc. Total Non Current Liabilities 2011-2026 | ALXN
Annual Total Non Current Liabilities Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.83 B | 5.08 B | 3.59 B | 3.74 B | 3.74 B | 4.16 B | 293 M | 353 M | 283 M | 30 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.08 B | 30 M | 2.61 B |
Total Non Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
40.2 M | - | 2.43 % | $ 254 M |  Germany |
 |
I-Mab
IMAB
|
131 M | - | - | $ 866 M |  China |
 |
Apellis Pharmaceuticals
APLS
|
289 M | $ 20.24 | -2.22 % | $ 2.55 B |  USA |
 |
Aptorum Group Limited
APM
|
2.21 M | $ 0.82 | -2.95 % | $ 4.47 M | China |
 |
Biophytis SA
BPTS
|
2.02 M | - | -13.47 % | $ 169 M |  France |
 |
Axsome Therapeutics
AXSM
|
48.9 M | $ 165.96 | -0.25 % | $ 8.26 B | USA |
 |
AbCellera Biologics
ABCL
|
326 M | $ 3.74 | -2.23 % | $ 1.12 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
6.39 M | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
110 K | - | -18.52 % | $ 27.3 M |  Britain |
 |
Codexis
CDXS
|
28.2 M | $ 0.97 | -4.87 % | $ 71.2 M | USA |
 |
Adverum Biotechnologies
ADVM
|
27.3 M | - | - | $ 86.2 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
648 K | $ 24.04 | 0.67 % | $ 2.94 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
541 M | - | - | - |  Russia |
 |
Corvus Pharmaceuticals
CRVS
|
2.31 M | $ 17.32 | -3.19 % | $ 832 M | USA |
 |
Champions Oncology
CSBR
|
1 M | $ 5.96 | -1.81 % | $ 81.4 M | USA |
 |
Daré Bioscience
DARE
|
1.39 M | $ 1.58 | -1.87 % | $ 13.4 M | USA |
 |
DBV Technologies S.A.
DBVT
|
7.14 M | $ 21.89 | -5.85 % | $ 2.12 B | France |
 |
ARCA biopharma
ABIO
|
409 K | - | 1052.0 % | $ 415 M | USA |
 |
Acer Therapeutics
ACER
|
244 K | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
15.9 M | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
257 M | - | -24.86 % | $ 820 K | USA |
 |
Capricor Therapeutics
CAPR
|
4.86 M | $ 25.75 | -4.13 % | $ 690 M | USA |
 |
Eton Pharmaceuticals
ETON
|
4.56 M | $ 17.52 | -3.47 % | $ 449 M | USA |
 |
Exelixis
EXEL
|
63.6 M | $ 40.72 | -0.76 % | $ 11.1 B | USA |
 |
Acasti Pharma
ACST
|
12.2 M | - | 4.01 % | $ 150 M | Canada |
 |
Amicus Therapeutics
FOLD
|
245 M | $ 14.35 | -0.1 % | $ 4.43 B | USA |
 |
Galectin Therapeutics
GALT
|
52 K | $ 2.9 | -5.23 % | $ 181 M | USA |
 |
CureVac N.V.
CVAC
|
112 M | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
19.1 M | - | 5.93 % | $ 314 M | Canada |
 |
Galapagos NV
GLPG
|
2.41 B | $ 32.94 | -3.37 % | $ 2.69 B |  Belgium |
 |
Greenwich LifeSciences
GLSI
|
9.5 M | $ 27.32 | -0.27 % | $ 356 M | USA |
|
Galecto
GLTO
|
541 K | $ 29.84 | -0.7 % | $ 793 M |  Danmark |
 |
Genmab A/S
GMAB
|
769 M | $ 27.53 | -7.17 % | $ 17.6 B | Danmark |
 |
Gossamer Bio
GOSS
|
37.2 M | $ 0.46 | 8.47 % | $ 70.2 M | USA |
 |
GeoVax Labs
GOVX
|
14.7 K | $ 1.53 | -1.92 % | $ 2.78 M | USA |
 |
Grifols, S.A.
GRFS
|
7.22 B | $ 8.54 | -6.11 % | $ 6.83 B |  Spain |
 |
AgeX Therapeutics
AGE
|
1.53 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
4.74 M | - | - | $ 1.01 B | USA |
 |
Halozyme Therapeutics
HALO
|
388 M | $ 69.01 | -1.2 % | $ 8.27 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
4.15 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
2.29 M | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
264 M | $ 3.17 | -5.09 % | $ 1.13 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
553 K | - | - | $ 7.46 M |  Israel |
 |
Hoth Therapeutics
HOTH
|
2.71 K | $ 0.99 | -2.47 % | $ 6.31 M | USA |
 |
Akero Therapeutics
AKRO
|
1.52 M | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
157 M | $ 28.49 | -2.57 % | $ 1.65 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
149 M | $ 28.56 | -1.18 % | $ 1.64 B | USA |
 |
Advaxis
ADXS
|
16 M | - | -9.65 % | $ 45.9 M | USA |